Navigation Links
Bayer and Onyx Announce Nexavar Data Presentations at 44th American Society of Clinical Oncology Annual Meeting
Date:5/15/2008

anderbilt-Ingram Cancer Center, Nashville, TN

-- Abstract #5011, Clinical Science Symposium, Saturday, May 31, 2008,

2:15 - 2:30 p.m., W375e

Lung Cancer

-- A randomized discontinuation Phase II study of sorafenib vs placebo in

patients with non-small cell lung cancer who have failed at least two

prior chemotherapy regimens

-- Joan Schiller, MD, professor and chief of the Hematology/Oncology

Division at University of Texas Southwestern and Andrea L. Simmons

Distinguished Chair in Cancer Research, Dallas, TX

-- Abstract #8014, Monday, June 2, 4 - 4:15 p.m., W375e

-- A Phase II trial of BAY 43-9006 in patients with platinum treated

extensive stage small cell lung cancer (E-SCLC): A SWOG (SO435) Phase

II trial

-- Barbara Gitlitz, MD, associate professor of clinical, director,

Lung, Head and Neck Program, USC/Norris Comprehensive Cancer Center,

Los Angeles, CA

-- Poster 20, abstract #8039, poster discussion, Monday, June 2, 2008,

12 - 1 p.m., W375d

Solid Tumors

-- A drug interaction study of sorafenib and rapamycin in patients with

advanced malignancies

-- Tara Gangadhar, MD, fellow, University of Chicago, Chicago, IL

-- Poster 10A, abstract #2545, poster discussion, Sunday, June 1, 2008,

2 - 6 p.m., S Hall A1

-- A phase II study: Combination of sorafenib with docetaxel and cisplatin

in the treatment of metastatic or advanced unresectable gastric and

gastroesophageal junction (GEJ) adenocarcinoma (ECOG 5203)

-- Weijing Sun, MD, assistant professor of medicine, University of

Pennsylvania (Philadelphia, PA) director of Upper GI and

Pancreatic-biliary-hepatic Cancer Group and the associate director

of the GI Cancer Program

-- Poster 23, abstract #4535, poster discussion, Tu
'/>"/>

SOURCE Bayer HealthCare Pharmaceuticals, Inc.; OnyxPharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Bayer CropSciences Vegetable Seed Business Nunhems Acquires US Lettuce Seed Company Paragon Seed
2. Pfizer, Genentech, Amgen, Bayer, Wyeth, Abbott, Merck and Additional Leading Pharmaceutical Companies Participating During ExL Pharmas Fall Line Up!
3. Indevus Comments on Bayer Healthcare Discontinuation of Viadur(R)
4. Bayer HealthCare Affiliate MEDRAD and Possis Medical Sign Definitive Merger Agreement
5. Accelerated Community Oncology Research Network, Inc. (ACORN), Initiates a Phase 2b Metastatic Breast Cancer Trial in Cooperation With Bayer and Onyx
6. Bayer HealthCare Pharmaceuticals Introduces VistaTrak(TM) an Innovative Contrast Media Management System
7. Bayer HealthCare Affiliate MEDRAD Successfully Completes Tender Offer for Shares of Possis Medical; Announces Subsequent Offering Period
8. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
9. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
10. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
11. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... March 02, 2015 Global ... formed alliance with Shenzhen HANK Bioengineering Co., Ltd. ... The alliance will establish a stem cells training ... China in September 2015. , Shenzhen HANK is ... an award-winning scientist, microbiologist and virologist, to integrate ...
(Date:3/1/2015)... 2015 Market Publishers Ltd and ... market research promotion on Internet. MarketPublishers.com is now ... out by DataGroup Booksellers. , Natalie Aster, Assistant ... commented on the recent partnership agreement as follows: ... our team of publishers. Since 1974, the company ...
(Date:2/27/2015)... (PRWEB) February 27, 2015 Immunovaccine Inc. ... aware of a fraudulent press release disseminated this morning ... be from Immunovaccine. This press release states that Immunovaccine ... Inc. The press release did not originate from ... contained within the press release. Please note that ...
(Date:2/27/2015)...  Pharmacyclics, Inc. (NASDAQ: PCYC ) ... newly developed Bruton,s tyrosine kinase (BTK) inhibitor for ... results of these preclinical evaluations have been communicated ... feedback received from the Agency is supportive of ... preclinical work is required to begin a Phase ...
Breaking Biology Technology:Global Stem Cells Group Announces Alliance with HANK Bioengineering Co., Ltd. in Shenzhen, China 2Global Stem Cells Group Announces Alliance with HANK Bioengineering Co., Ltd. in Shenzhen, China 3Market Publishers Ltd and DataGroup Booksellers Sign Partnership Agreement 2Market Publishers Ltd and DataGroup Booksellers Sign Partnership Agreement 3Immunovaccine Disclaims Hoax Press Release 2Pharmacyclics Provides Clinical Update on BTK Inhibitor for Autoimmune Diseases 2Pharmacyclics Provides Clinical Update on BTK Inhibitor for Autoimmune Diseases 3
... Feb. 8 /PRNewswire-FirstCall/ - Diagnostic Imaging,International Corp. (OTCBB: ... a number of diagnostic imaging clinics for acquisition., ... plans to,acquire a number of profitable operating clinics ... Company management has begun its diligence review ...
... patients treated with,Myobloc(R) (Botulinum Toxin Type B) Injectable ... Neurosciences, Inc. ("Solstice"). We,support education and training of ... use of this product as outlined in the ... routine process for monitoring and reporting,any adverse events ...
... 8 Exelixis,Inc. (Nasdaq: EXEL ) will release ... Thursday, February 14, 2008 after the markets close.,The announcement ... p.m. ET/ 2:00,p.m. PT, in which Exelixis management will ... webcast may be accessed in the Event,Calendar page under ...
Cached Biology Technology:Diagnostic Imaging - Acquisitions - OTCBB: DIIG 2Solstice Neurosciences, Inc. Issues Corporate Response to FDA Early Communication 2
(Date:2/11/2015)... , February 11, 2015 ... report "Access Control Market by Product (Cards and Readers, ... Military and Defense, Government, Industrial, Healthcare, Education) and By ... by MarketsandMarkets, the Access Control Market is ... growing at a CAGR of 10.6% between ...
(Date:2/9/2015)... 2015  Lintec of America recently announced an exclusive ... (CNT) macrostructures, including sheets, yarns and ribbons, developed at ... Leveraging the vast industrial resources of the global Lintec ... Lintec of America is forming the Nano-Science and Technology ... focusing on scaling up the manufacturing and commercialization of ...
(Date:2/5/2015)... , Feb. 5, 2015  Marken is starting its ... and has launched a new marketing campaign to solidify ... (CLO).  The new campaign focuses on First ... and shipments. The first headline in the ... Marken,s priorities with its client,s priorities. Marken recognizes the ...
Breaking Biology News(10 mins):Access Control Market Worth $10.4 Billion by 2020 2Access Control Market Worth $10.4 Billion by 2020 3Access Control Market Worth $10.4 Billion by 2020 4Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 4Marken Launches New Patient-Centric Campaign 2
... at the University of Huddersfield aims to ensure that the risk ... of lead plumbing is reduced even further in line with ... 2013. The project is being conducted in collaboration with ... countries, such as European nations and the USA, have similar issues ...
... coin. It refers simultaneously to that which is visible and ... hidden. This less-visible hunger is known as ,hidden hunger, or ... the consequences of hidden hunger before they are five years ... the physical torture of starvation, which is responsible for the ...
... new direction in examining the availability of healthy foods ... its residents. This new approach to identifying so-called ... May journal of Health and Place . ... options such as fresh fruits and vegetables ...
Cached Biology News:Research with Yorkshire Water to reduce lead in water supplies 2Malnutrition -- Living hungrily ever after 2UC research takes a new approach to identifying 'food deserts' 2
HAS1 (C-14)...
Complete cell culture media with cytokines...
... provide flexible sealing lips for products ... ,PFG: Flat cup ,PBG: Bellows cup ... Bellows cup , Range of ... mm , Multiple suction cup materials ...
Total Proteins from over 50 different human Alzheimer, Diabetic, Liver Cirrhosis, and Lupus diseased tissues are available....
Biology Products: